Details of the Drug

General Information of Drug (ID: DMS23ON)

Drug Name

FF21101

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02454010) A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer. U.S. National Institutes of Health.